Spectral Medical Inc
OTC:EDTXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Spectral Medical Inc
OTC:EDTXF
|
CA |
|
V
|
Vaxcell Bio Therapeutics
KOSDAQ:323990
|
KR |
|
C
|
Chow Tai Fook Jewellery Group Ltd
XMUN:1CT
|
HK |
|
S
|
Schneider Electric SE
XMUN:SND
|
FR |
|
Tokyo Century Corp
F:59O
|
JP |
|
Anima Holding SpA
MIL:ANIM
|
IT |
|
I
|
Ingredion Inc
SWB:CNP
|
US |
|
F
|
Fine Metal Technologies PCL
SET:FMT
|
TH |
|
C
|
CapitaLand Ascendas REIT
OTC:ACDSF
|
SG |
|
I
|
Installed Building Products Inc
SWB:2IL
|
US |
|
T
|
Thales SA
XMUN:CSF
|
FR |
|
Q
|
Qingdao Port International Co Ltd
XMUN:0QP
|
CN |
|
M
|
Monster Beverage Corp
SWB:MOB
|
US |
|
X
|
Xtb SA
WSE:XTB
|
PL |
|
DiaSorin SpA
OTC:DSRLF
|
IT |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
Siemens AG
F:SIE
|
DE |
|
W
|
Wellness Matrix Group Inc
OTC:WMGR
|
US |
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
|
NZ |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
A
|
Afi Properties Ltd
TASE:AFPR
|
IL |
|
R
|
Rogers Corp
F:RG6
|
US |
|
Softcat PLC
LSE:SCT
|
UK |
Wall St Price Targets
EDTXF Price Targets Summary
Spectral Medical Inc
According to Wall Street analysts, the average 1-year price target for
EDTXF is 2.292 USD with a low forecast of 2.017 USD and a high forecast of 2.622 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EDTXF's stock price target?
Price Target
2.292
USD
According to Wall Street analysts, the average 1-year price target for
EDTXF is 2.292 USD with a low forecast of 2.017 USD and a high forecast of 2.622 USD.
What is the Revenue forecast for Spectral Medical Inc?
Projected CAGR
109%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 109%.
What is the Gross Profit forecast for Spectral Medical Inc?
Projected CAGR
120%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 8 years is 120%.